
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 27, 2023, titled "Sun Pharma Canada Launches PRWINLEVI�� (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne".
Filed with NSE ·

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated September 27, 2023, titled "Sun Pharma Canada Launches PRWINLEVI�� (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne".
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries